|
|
|
Insider
Information: |
Scangos George A |
Relationship: |
Director |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
934,251 |
|
Indirect Shares
|
3,765,803 |
|
|
Direct
Value |
$30,246,957 |
|
|
Indirect Value
|
$5,264,656 |
|
|
Total
Shares |
4,700,054 |
|
|
Total
Value |
$35,511,613 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
Agilent Technologies Inc |
A |
Director |
2024-05-29 |
18,578 |
2024-05-29 |
17,893 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
378 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 15 of 16
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
EXEL |
Exelixis Inc |
President, CEO & Director |
|
2003-10-29 |
4 |
S |
$7.27 |
$18,189 |
D/D |
(2,500) |
1,712,341 |
|
- |
|
EXEL |
Exelixis Inc |
President, CEO & Director |
|
2003-10-21 |
4 |
S |
$7.20 |
$18,034 |
D/D |
(2,500) |
1,714,841 |
|
- |
|
EXEL |
Exelixis Inc |
President, CEO & Director |
|
2003-10-15 |
4 |
S |
$8.06 |
$20,293 |
D/D |
(2,500) |
1,717,341 |
|
- |
|
EXEL |
Exelixis Inc |
President, CEO & Director |
|
2003-10-09 |
4 |
S |
$7.80 |
$601,536 |
D/D |
(77,120) |
1,719,841 |
|
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-09-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,750,000 |
1,750,000 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-10-17 |
4 |
A |
$0.00 |
$0 |
I/I |
3,500,000 |
1,750,000 |
0 |
- |
|
EXEL |
Exelixis Inc |
President, CEO & Director |
|
2003-10-08 |
4 |
S |
$7.73 |
$19,325 |
D/D |
(2,500) |
1,796,961 |
|
- |
|
EXEL |
Exelixis Inc |
President, CEO & Director |
|
2003-10-02 |
4 |
S |
$7.75 |
$19,370 |
D/D |
(2,500) |
1,799,461 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-09-26 |
4 |
S |
$7.31 |
$18,269 |
D/D |
(2,500) |
1,801,961 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-09-15 |
4 |
S |
$8.40 |
$20,994 |
D/D |
(2,500) |
1,804,461 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-09-10 |
4 |
S |
$7.88 |
$19,704 |
D/D |
(2,500) |
1,806,961 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-09-04 |
4 |
S |
$7.67 |
$19,180 |
D/D |
(2,500) |
1,809,461 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-08-27 |
4 |
S |
$7.25 |
$18,125 |
D/D |
(2,500) |
1,811,961 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-08-20 |
4 |
S |
$7.31 |
$18,277 |
D/D |
(2,500) |
1,814,461 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-08-13 |
4 |
S |
$6.80 |
$17,012 |
D/D |
(2,500) |
1,816,961 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-08-06 |
4 |
S |
$7.06 |
$17,660 |
D/D |
(2,500) |
1,819,461 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-07-31 |
4 |
S |
$8.29 |
$20,718 |
D/D |
(2,500) |
1,821,961 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-07-23 |
4 |
S |
$8.11 |
$20,264 |
D/D |
(2,500) |
1,824,461 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-07-14 |
4 |
S |
$9.15 |
$22,863 |
D/D |
(2,500) |
1,826,961 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-07-11 |
4 |
S |
$9.01 |
$22,522 |
D/D |
(2,500) |
1,829,461 |
|
- |
|
EXEL |
Exelixis Inc |
officerTitle |
|
2003-07-03 |
4 |
S |
$7.56 |
$18,910 |
D/D |
(2,500) |
1,831,961 |
|
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2020-04-14 |
4 |
D |
$29.56 |
$6,999,985 |
I/I |
(236,806) |
1,907,329 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2023-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750,000 |
1,918,489 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEOOfficer |
|
2019-10-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,222,222 |
|
- |
|
VIR |
Vir Biotechnology, Inc. |
President and CEO |
|
2023-01-18 |
4 |
AS |
$0.00 |
$0 |
I/I |
(64,930) |
3,533,629 |
0 |
- |
|
378 Records found
|
|
Page 15 of 16 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|